Comparison of COVID-19 vaccine prioritization strategies
View ORCID ProfileLloyd A. C. Chapman, Poojan Shukla, View ORCID ProfileIsabel Rodríguez-Barraquer, View ORCID ProfilePriya B. Shete, View ORCID ProfileTomás M. León, View ORCID ProfileKirsten Bibbins-Domingo, View ORCID ProfileGeorge W. Rutherford, Robert Schechter, View ORCID ProfileNathan C. Lo
doi: https://doi.org/10.1101/2021.03.04.21251264
Lloyd A. C. Chapman
1Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
PhDPoojan Shukla
1Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
2Department of Bioengineering, University of California, Berkeley, Berkeley, CA, USA
Isabel Rodríguez-Barraquer
1Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
3Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA
MD PhDPriya B. Shete
4Coronavirus Sciences Branch, California Department of Public Health, Richmond, CA, USA
5Division of Pulmonary and Critical Care Medicine and Center for Tuberculosis, University of California San Francisco, CA, USA
MD, MPHTomás M. León
4Coronavirus Sciences Branch, California Department of Public Health, Richmond, CA, USA
MSc PhDKirsten Bibbins-Domingo
1Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
6Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA
MD PhDGeorge W. Rutherford
6Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA
7Institute for Global Health Sciences, University of California, San Francisco, San Francisco, CA, USA
MDRobert Schechter
8Immunization Branch, California Department of Public Health, Richmond, CA, USA
MDNathan C. Lo
1Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
MD PhDData Availability
All analysis code is available online at https://github.com/LloydChapman/COVIDVaccineModelling. The California Department of Public Health case data required for fitting the Poisson regression model contain personally identifiable information and therefore cannot be made freely available. Individuals interested in accessing the data should contact the California Department of Public Health. The simulated population data required to run the vaccine prioritization simulations is available at http://doi.org/10.5281/zenodo.4516526.
Posted June 10, 2021.
Comparison of COVID-19 vaccine prioritization strategies
Lloyd A. C. Chapman, Poojan Shukla, Isabel Rodríguez-Barraquer, Priya B. Shete, Tomás M. León, Kirsten Bibbins-Domingo, George W. Rutherford, Robert Schechter, Nathan C. Lo
medRxiv 2021.03.04.21251264; doi: https://doi.org/10.1101/2021.03.04.21251264
Comparison of COVID-19 vaccine prioritization strategies
Lloyd A. C. Chapman, Poojan Shukla, Isabel Rodríguez-Barraquer, Priya B. Shete, Tomás M. León, Kirsten Bibbins-Domingo, George W. Rutherford, Robert Schechter, Nathan C. Lo
medRxiv 2021.03.04.21251264; doi: https://doi.org/10.1101/2021.03.04.21251264
Subject Area
Subject Areas
- Addiction Medicine (379)
- Allergy and Immunology (694)
- Anesthesia (186)
- Cardiovascular Medicine (2806)
- Dermatology (241)
- Emergency Medicine (424)
- Epidemiology (12492)
- Forensic Medicine (10)
- Gastroenterology (796)
- Genetic and Genomic Medicine (4360)
- Geriatric Medicine (397)
- Health Economics (710)
- Health Informatics (2805)
- Health Policy (1041)
- Hematology (372)
- HIV/AIDS (888)
- Medical Education (410)
- Medical Ethics (113)
- Nephrology (458)
- Neurology (4127)
- Nursing (219)
- Nutrition (612)
- Oncology (2178)
- Ophthalmology (616)
- Orthopedics (253)
- Otolaryngology (315)
- Pain Medicine (260)
- Palliative Medicine (80)
- Pathology (482)
- Pediatrics (1166)
- Primary Care Research (478)
- Public and Global Health (6719)
- Radiology and Imaging (1475)
- Respiratory Medicine (893)
- Rheumatology (427)
- Sports Medicine (359)
- Surgery (468)
- Toxicology (57)
- Transplantation (197)
- Urology (173)